The role of B-cell ferroptosis in the pathogenesis of systemic lupus erythematosus

Clin Immunol. 2023 Sep 18:109778. doi: 10.1016/j.clim.2023.109778. Online ahead of print.ABSTRACTSystemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the dysregulation of B cell subpopulation and function. Recent studies have suggested a potential role of ferroptosis, an iron-dependent form of regulated cell death, in the pathogenesis of SLE. Here, we demonstrate that B-cell ferroptosis occurs both in lupus patients and MRL/lpr mice. Treatment with liproxstatin-1, a potent ferroptosis inhibitor, could reduce autoantibody production, improve renal damage, and alleviate lupus symptoms in vivo. Furthermore, our results suggest that ferroptosis may regulate B cell differentiation and plasma cell formation, indicating a potential mechanism for its involvement in SLE. Taken together, targeting ferroptosis in B cells may be a promising therapeutic strategy for SLE.PMID:37730009 | DOI:10.1016/j.clim.2023.109778
Source: Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research